Search For "controller"
Proven record for safety, says Bharat Biotech after Covaxin gets emergency
Updated : 4 years, 2 months ago IST
New Delhi [India], December 25 (ANI): Covaxin has a proven record for safety and efficacy from all the variants of COVID-19, said Bharat Biotech after its vaccine received emergency usage approval from the Drugs Controller General of India (DCGI) for kids aged between 12-18 years.
Read More
Bharat Biotech's Covaxin gets emergency use approval from DCGI for kids ab
Updated : 4 years, 2 months ago IST
New Delhi [India], December 25 (ANI): Bharat Biotech's COVID-19 vaccine Covaxin has received approval from the Drugs Controller General of India (DCGI) for emergency use for kids aged between 12-18 years, official sources said.
Read More
Bharat Biotech seeks DCGI's approval for its intranasal COVID-19 booster d
Updated : 4 years, 2 months ago IST
New Delhi [India], December 20 (ANI): As India is witnessing a surge in cases of "highly transmissible" Omicron variant, Hyderabad-based Bharat Biotech has submitted the phase 3 clinical trial application to the Drugs Controller General of India (DCGI) to get approval for the booster dose
Read More
Sony announces console covers, DualSense controller colours for PlayStatio
Updated : 4 years, 3 months ago IST
Washington [US], December 14 (ANI): Game fanatics have a reason to rejoice as for the first time, Sony on Monday announced its range of first-party console covers for the PlayStation 5 and also three new colours for the DualSense controller.
Read More
Algorithmic Biologics receives CE Mark for its compressed molecular testin
Updated : 4 years, 3 months ago IST
Bangalore (Karnataka) [India], December 9 (ANI/BusinessWire India): Algorithmic Biologics, a deep-tech startup building algorithms for molecular programming, today announced that it has received ConformiteEuropeene (CE) Mark approval for its proprietary compressed molecular testing method ca
Read More
Zydus seeks DCGI nod for 'Desidustat' oral pill to treat anaemia in kidney
Updated : 4 years, 3 months ago IST
Ahmedabad (Gujarat) [India], November 23 (ANI): Pharmaceutical company Zydus Cadila on Tuesday announced that it has submitted its first "New Drug Application (NDA)" to the Drug Controller General of India for its oral pill "Desidustat" to treat anaemia in kidney patients.
Read More
Himachal HC issues notice on sheer negligence in evaluation of answer shee
Updated : 4 years, 4 months ago IST
Shimla (Himachal Pradesh) [India], November 17 (ANI): The High Court of Himachal Pradesh on Wednesday issued notices to the Registrar and the Examination Controller of Himachal Pradesh University to reply within three weeks in a matter related to sheer negligence in the evaluation of the ans
Read More
Covaxin for Children will take some more time for final approval: Sources
Updated : 4 years, 4 months ago IST
New Delhi [India], November 8 (ANI): The data for Bharat Biotech's Covaxin for Children, COVID-19 vaccine, is under evaluation and the process will take some more time for final approval from the Drugs Controller General of India (DCGI), sources said.
Read More
We are waiting for DCGI approval for children's COVID-19 vaccine: Bharat B
Updated : 4 years, 4 months ago IST
New Delhi [India], October 23(ANI): Chairman and Managing Director of Bharat Biotech, Dr. Krishna Ella on Saturday said that they are waiting for approval from the Drugs Controller General of India (DCGI) for the COVID-19 vaccine for children.
Read More
Class 10, 12 board exams in two parts will reduce stress level of students
Updated : 4 years, 5 months ago IST
New Delhi [India], October 19 (ANI): Sanyam Bhardwaj, the Examination controller of the Central Board of Secondary Education (CBSE) on Tuesday said that conducting class 10 and12 board examinations in two parts will reduce the stress level of students.
Read More
Awaiting regulatory approval for rolling out Covaxin for children aged 2-1
Updated : 4 years, 5 months ago IST
New Delhi [India], October 12 (ANI): The Subject Expert Committee (SEC) has given a recommendation to the Drugs Controller General of India (DCGI) for the use of Bharat Biotech's COVID-19 vaccine, Covaxin, for the beneficiaries aged between 2-18 years, the official sources said on Tuesday
Read More
Approval to Covaxin for children aged between 2-18 years awaited after eva
Updated : 4 years, 5 months ago IST
New Delhi [India], October 12 (ANI): After the evaluation of data Covaxin is yet to get approval by the Drugs Controller General of India (DCGI) for children between 2-18 years old, according to official sources.
Read More